Growth differentiation factor 15 and arterial remodeling in adult patients after succesful repair of aortic coarctation (RCD code: IV-5.A.1)
Journal Title: Journal of Rare Cardiovascular Diseases - Year 2013, Vol 1, Issue 2
Abstract
Background: Coarctation of aorta (CoAo) is a congenital heart anomaly associated with high cardiovascular morbidity and mortality attributable to vascular remodeling in adult survivors following surgical management of aortic stenosis. This study sought to adjudicate the significance of novel stress-responsive biomarker, growth differentiation factor 15 (GDF-15), as an indicator of vascular remodeling and its correlation with numerous laboratory and vascular parameters in patients after successful CoAo repair.Methods and results: This research is a case-control study comprising 33 consecutive patients (19 men, 57.58%; mean age 33.9 ±9.3 years; mean age at surgery: 9.1 ±7 years; mean follow-up duration 24.8 ±6.8 years) admitted to outpatient clinic for routine follow-up after repair of CoAo (mainly Dacron patch technique) and matched with 20 healthy controls (10 men, 50%; mean age 34.8 ±9.9 years). Laboratory (GDF-15, high-sensitivity C-reactive protein) and vascular parameters (intima-media thickness, flow- and nitrate-mediated dilation, pulse-wave velocity, central arterial pressure) were assessed. Significant aortic residual gradient was present in 24 (72.7%). The circulating GDF-15 level was lower in CoAo survivors than in control group (539.56 vs. 744.98 pg/ml respectively; p < 0.001). GDF-15 concentration <550 pg/ml successfully differentiated patients after CoA repair (odds ratio [OR] = 9.2; 95%CI: 2.45–34.56, p = 0.0005). There was no difference in GDF-15 level depending on the presence of significant residual gradient (p = 0.19). No significant correlation between GDF-15 and other variables was observed. Conclusions: Low concentration of GDF-15 is characteristic of asymptomatic patients following CoAo repair, however, its clinical significance and relationship with vascular remodeling substantiates further investigation. JRCD2013; 1 (2): 5–12Key words: coarctation of aorta, GDF-15, growth differentiation factor 15, vascular remodeling
Authors and Affiliations
Katarzyna Mizia-Stec, Maciej Wybraniec, Olga Trojnarska, Jerzy Chudek
Keywords
Related Articles
- EP ID EP245377
- DOI 10.20418/jrcd.vol1no2.77
- Views 90
- Downloads 0
Metastatic tumor of the left atrium (RCD code: VI‑2O)
We present a case report concerning a 59-year-old patient diagnosed with intracardiac tumor two years after removal of soft tissue sarcoma of the right lower extremity.
“A rare day to put rare diseases in the spotlight!” “With research possibilities are limitless”
Just few days ago, on 28th February, the tenth edition of Rare Disease Day was launched by EURORDIS and its Council for National Alliances to attract thousands people all over the world to come together to advocate for m...
Overlap cardiomyopathy – coexistence of hypertrophic and restrictive cardiomyopathy phenotypes in one patient (RCD code: III-2A.1)
Recent data indicate that substantial proportion of cardiomyopathy patients have in fact more than one phenotype, the phenomenon termed as overlap or mixed cardiomyopathy. The molecular mechanisms and pathology as well a...
Current views on the use of interferons in the treatment of polycythaemia vera
Interferon alpha is a molecule associated with stimulation of immune system cells, resulting in an anti‐proliferative and immunomodulatory effect. It has been demonstrated that interferon reduces the number of platelets,...
Establishing a curriculum on rare diseases for medical students
Healthcare workers often have insufficient knowledge on rare diseases that may lead to delay in making a diagnosis and providing appropriate care. The fifth area of the Europlan entitled: “Gathering The Expertise On Rar...